These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15513938)

  • 1. Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats.
    Jackson DN; Milne KJ; Noble EG; Shoemaker JK
    J Physiol; 2005 Jan; 562(Pt 1):285-94. PubMed ID: 15513938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y1- and alpha1-receptor control of basal hindlimb vascular tone.
    Jackson DN; Noble EG; Shoemaker JK
    Am J Physiol Regul Integr Comp Physiol; 2004 Jul; 287(1):R228-33. PubMed ID: 15044188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-diabetes augments neuropeptide Y1- and α1-receptor control of basal hindlimb vascular tone in young ZDF rats.
    Novielli NM; Al-Khazraji BK; Medeiros PJ; Goldman D; Jackson DN
    PLoS One; 2012; 7(10):e46659. PubMed ID: 23071607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats.
    Jackson DN; Milne KJ; Noble EG; Shoemaker JK
    J Physiol; 2005 Oct; 568(Pt 2):573-81. PubMed ID: 16081487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats.
    Jackson DN; Ellis CG; Shoemaker JK
    Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1351-7. PubMed ID: 20219870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-adrenergic and neuropeptide Y Y1 receptor control of collateral circuit conductance: influence of exercise training.
    Taylor JC; Yang HT; Laughlin MH; Terjung RL
    J Physiol; 2008 Dec; 586(24):5983-98. PubMed ID: 18981031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
    Chen SH; Cheung RT
    Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV; Steiner M; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y Y1 receptor blockade does not alter adrenergic nerve responses of the rat tail artery.
    Duckles SP; Adner M; Edvinsson L; Krause DN
    Eur J Pharmacol; 1997 Dec; 340(1):75-9. PubMed ID: 9527509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat?
    Zhao XH; Sun XY; Edvinsson L; Hedner T
    J Hypertens; 1997 Jan; 15(1):19-27. PubMed ID: 9050966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat.
    Yang SN; Finnman UB; Fuxe K
    Neuroreport; 1996 Nov; 7(15-17):2701-5. PubMed ID: 8981451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
    Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
    Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
    Yang XP; Chiba S
    Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo.
    Malmström RE; Balmér KC; Weilitz J; Nordlander M; Sjölander M
    Eur J Pharmacol; 2001 Apr; 418(1-2):95-104. PubMed ID: 11334870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii.
    Yang SN; Fior DR; Hedlund PB; Agnati LF; Fuxe K
    Eur J Pharmacol; 1994 Dec; 271(1):201-12. PubMed ID: 7698202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the neuropeptide YY1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo .
    Malmström RE; Lundberg JM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):633-42. PubMed ID: 8938663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 neuropeptide Y receptors and alpha1-adrenoceptors in the neural control of regional renal perfusion.
    Eppel GA; Luff SE; Denton KM; Evans RG
    Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R331-40. PubMed ID: 16195497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles.
    Buckwalter JB; Hamann JJ; Clifford PS
    J Appl Physiol (1985); 2005 Dec; 99(6):2115-20. PubMed ID: 16099895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.